https://www.healthcareit.com.au/article/murrumbidgee-local-health...

https://www.healthcareit.com.au/art...istrict-roll-out-new-hit-deployments-alcidion

TOP STORY
Murrumbidgee Local Health District to roll out new HIT deployments with Alcidion
Dean Koh | 15 Jul 2020
ELECTRONIC HEALTH RECORDS




Murrumbidgee Local Health District (MLHD), in New South Wales (NSW), Australia has signed two contracts with healthcare software solutions provider Alcidion to continue use of Alcidion’s Miya Precision platform, including the Miya MEMRe mobile application and for related professional services.

Earlier this year, MLHD elected to use Miya Precision for a period of 12 months from January 1, 2020. Two contracts confirming the scope of intended use at Wagga Wagga Base Hospital and an extended scope of professional services for this initial 12 months have now been signed.

The confirmed contracted scope of initial deployment includes implementing a COVID-19 monitoring dashboard for Miya Precision, designed to enable the monitoring of COVID-19 positive, and at-risk patients, both in-hospital and remotely. Miya MEMRe will also be rolled out to up to 200 clinicians, which will reduce the risk of infection from using shared devices. Miya Precision and MEMRe are drawing on data from the state-wide electronic medical record.

THE LARGER TREND

In March, ACT Health, the public health agency of the Australian Capital Territory (ACT), went live with Miya Precision at two campuses – Canberra Hospital and The University of Canberra Hospital.

Last November, Alcidion launched Miya MEMRe, a mobile electronic medical record (EMR), which provides clinicians with access to caseloads, critical issues and comprehensive patient records on the go, Healthcare IT News reported.

ON THE RECORD

“We are delighted that MLHD has elected to use Miya Precision and MEMRe. Furthermore, we are pleased to work with the team at MLHD to further develop the COVID-19 monitoring solution to meet their needs as they utilize vital resources to manage the impact of this ongoing situation,” said Kate Quirke, Managing Director of Alcidion.